F046-0249 Screening compound: N-[(3-chlorophenyl)methyl]-2-[6-oxo-3-(4-phenylpiperazin-1-yl)-1,6-dihydropyridazin-1-yl]acetamide

F046-0249 Screening compound: N-[(3-chlorophenyl)methyl]-2-[6-oxo-3-(4-phenylpiperazin-1-yl)-1,6-dihydropyridazin-1-yl]acetamide
F046-0249 Screening compound: N-[(3-chlorophenyl)methyl]-2-[6-oxo-3-(4-phenylpiperazin-1-yl)-1,6-dihydropyridazin-1-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F046-0249
N-[(3-chlorophenyl)methyl]-2-[6-oxo-3-(4-phenylpiperazin-1-yl)-1,6-dihydropyridazin-1-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F046-0249

Molecular Formula

C23H24ClN5O2 (C23 H24 ClN5 O2)

Compound Name

N-[(3-chlorophenyl)methyl]-2-[6-oxo-3-(4-phenylpiperazin-1-yl)-1,6-dihydropyridazin-1-yl]acetamide

IUPAC name

N-[(3-chlorophenyl)methyl]-2-[6-oxo-3-(4-phenylpiperazin-1-yl)-16-dihydropyridazin-1-yl]acetamide

SMILES

O=C(CN(C(C=C1)=O)N=C1N(CC1)CCN1c1ccccc1)NCc1cccc(Cl)c1

InChI

InChI=1S/C23H24ClN5O2/c24-19-6-4-5-18(15-19)16-25-22(30)17-29-23(31)10-9-21(26-29)28-13-11-27(12-14-28)20-7-2-1-3-8-20/h1-10,15H,11-14,16-17H2,(H,25,30)

InChI Key

LRLRWKDMNQKHDT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD18069958

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

437.93

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.054

Distribution Coefficient, logD

3.053

Water Solubility, LogSw

-3.48

Polar Surface Area

59.856

Acid Dissociation Constant (pKa)

13.57

Base Dissociation Constant (pKb)

5.83

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.10

F046-0249 in Drug Discovery

Included in Screening Libraries

Antiviral Annotated Library (21441 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

Human Proteases Annotated Library (2868 compounds)

Human Transcription Factors Annotated Library (5098 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system

References: we are preparing a list of scientific research reports with F046-0249 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F046-0249?
Check Price and Availability of F046-0249, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F046-0249 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F046-0249
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F046-0249
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F046-0249 available by request